Evidence map›Paper›PMID 33450539›Full record

ArticleBlood cells, molecules & diseases2021

Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?

Timothy M Bahr, Diane M Ward, Xuan Jia, Robin K Ohls, Kendell R German, Robert D Christensen

Open access · greenAbstract read
In one paragraph

Article in Blood cells, molecules & diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Anemia, Iron Supplementation, and the Brain.Clinics in perinatology · 2023
    Review
  5. Article
  6. Impact and interactions between risk factors on the iron status of at-risk neonates.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  7. Review
  8. Serum erythroferrone levels during the first month of life in premature infants.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Timothy M BahrDivision of Neonatology, University of Utah Health, Salt Lake City, UT, USA. Electronic address: Tim.Bahr@hsc.utah.edu.
Diane M WardDepartment of Pathology, University of Utah Health, Salt Lake City, UT, USA; Center for Iron and Heme Disorders, University of Utah, Salt Lake City, UT, USA.
Xuan JiaDepartment of Pathology, University of Utah Health, Salt Lake City, UT, USA.
Robin K OhlsDivision of Neonatology, University of Utah Health, Salt Lake City, UT, USA.
Kendell R GermanDivision of Neonatology, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Robert D ChristensenDivision of Neonatology, University of Utah Health, Salt Lake City, UT, USA; Division of Hematology/Oncology, Department of Pediatrics, University of Utah Health, Salt Lake City, UT, USA; Center for Iron and Heme Disorders, University of Utah, Salt Lake City, UT, USA; Women and Newborns Research, Intermountain Healthcare, Murray, UT, USA.
University of Utah · USIntermountain Healthcare · USUniversity of Washington · US

Funding

Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
NIDDK NIH HHS U54 DK110858
6 · The paper itself

Abstract

In a two-part process, we assessed elements of the principal hormonal pathway regulating iron homeostasis in human neonates. Part 1: Quantifying erythropoietin (Epo), erythroferrone (ERFE), hepcidin, and relevant serum and erythrocytic iron-related metrics in umbilical cord blood from term (n = 13) and preterm (n = 10) neonates, and from neonates born to mothers with diabetes and obesity (n = 13); Part 2: Quantifying serum Epo, ERFE, and hepcidin before and following darbepoetin administration. Part 1: We measured Epo, ERFE and hepcidin in all cord blood samples. Epo and ERFE levels did not differ between the three groups. Preterm neonates had the lowest hepcidin levels, while neonates born to diabetic women with a very high BMI had the lowest ferritin and RET-He levels. Part 2: Following darbepoetin dosing, ERFE levels generally increased (p < 0.05) and hepcidin levels generally fell (p < 0.05). Our observations suggest that the Epo/ERFE/hepcidin axis is intact in the newborn period.

Indexed as

Signal TransductionErythropoietinFemaleFetal BloodHepcidinsHumansInfant, NewbornInfant, PrematureMaleObesityPeptide HormonesPregnancyPregnancy ComplicationsPregnancy in DiabeticsPremature BirthEPO protein, humanErfe protein, humanErythropoietinHAMP protein, humanHepcidinsPeptide HormonesErythroferroneErythropoietinHepcidinIronRET-HeSupplementation

Identifiers

PMID33450539
PMCPMC9107158
OpenAlexW3118319062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.